# Trachoma Elimination Follow-up

> **NCT00221364** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 20000 (estimated)

## Conditions studied

- Trachoma
- Chlamydia

## Interventions

- **DRUG:** Mass treatment with oral azithromycin to an entire village

## Key facts

- **NCT ID:** NCT00221364
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2005-04
- **Final completion:** 2005-04
- **Target enrollment:** 20000 (ESTIMATED)
- **Last updated:** 2015-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00221364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00221364, "Trachoma Elimination Follow-up". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00221364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*